N-(4-Methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetamide

Catalog No. :
ACESWQ759
CAS No. :
1172115-34-2
Molecular Formula :
C15H22BNO3
Molecular Weight :
275.16

IUPAC Name:N-(4-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetamide

N-(4-Methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g98%$110.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-(4-Methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetamide
IUPAC NameN-(4-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetamide
MDL No.MFCD22493971
Molecular FormulaC15H22BNO3
Molecular Weight275.16
SMILESCC(NC1=CC=C(C)C(B2OC(C)(C)C(C)(C)O2)=C1)=O
InChI KeyFZCGDFRZNKWEBS-UHFFFAOYSA-N
SynonymAcetamide, N-[4-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-;N-(4-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetamide
CAS No.1172115-34-2
PubChem CID58164864

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319
Precautionary Statement(s)
P264-P280-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364

Synthetic Route by SureRoute

1. ACESWQ759 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3 In Stock
  4. Then
  5. ACESWQ759 route product structure diagram
    ACESWQ7591172115-34-2
Inquiry

2. ACESWQ759 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACRAWC965 route compound structure diagram
    ACRAWC965882670-69-1 In Stock
  4. Then
  5. ACESWQ759 route product structure diagram
    ACESWQ7591172115-34-2
Inquiry

Comments (0)